Tag
MAPS Public Benefit Corporation
Investors wince as FDA panel rejects proposal to approve 'molly' for PTSD therapy
Rowan Dunne · Jun 6, 2024
MAPS subsidiary raises over US$100M to support MDMA regulation
Rowan Dunne · Jan 6, 2024
FDA lifts ban on study of therapists taking MDMA
Natalia Buendia Calvillo · May 14, 2021